ENTRY       3553              CDS       T01001
NAME        IL1B, IL-1, IL1-BETA, IL1F2
DEFINITION  (RefSeq) interleukin 1 beta
ORTHOLOGY   K04519  interleukin 1 beta
ORGANISM    hsa  Homo sapiens (human)
PATHWAY     hsa01523  Antifolate resistance
            hsa04010  MAPK signaling pathway
            hsa04060  Cytokine-cytokine receptor interaction
            hsa04064  NF-kappa B signaling pathway
            hsa04217  Necroptosis
            hsa04380  Osteoclast differentiation
            hsa04620  Toll-like receptor signaling pathway
            hsa04621  NOD-like receptor signaling pathway
            hsa04623  Cytosolic DNA-sensing pathway
            hsa04640  Hematopoietic cell lineage
            hsa04657  IL-17 signaling pathway
            hsa04659  Th17 cell differentiation
            hsa04668  TNF signaling pathway
            hsa04750  Inflammatory mediator regulation of TRP channels
            hsa04932  Non-alcoholic fatty liver disease (NAFLD)
            hsa04933  AGE-RAGE signaling pathway in diabetic complications
            hsa04940  Type I diabetes mellitus
            hsa05010  Alzheimer's disease
            hsa05020  Prion diseases
            hsa05132  Salmonella infection
            hsa05133  Pertussis
            hsa05134  Legionellosis
            hsa05140  Leishmaniasis
            hsa05142  Chagas disease (American trypanosomiasis)
            hsa05143  African trypanosomiasis
            hsa05144  Malaria
            hsa05146  Amoebiasis
            hsa05152  Tuberculosis
            hsa05162  Measles
            hsa05164  Influenza A
            hsa05168  Herpes simplex infection
            hsa05321  Inflammatory bowel disease (IBD)
            hsa05323  Rheumatoid arthritis
            hsa05332  Graft-versus-host disease
            hsa05418  Fluid shear stress and atherosclerosis
DISEASE     H01492  Systemic sclerosis
DRUG_TARGET Canakinumab: D09315
            Rilonacept: D06635
BRITE       KEGG Orthology (KO) [BR:hsa00001]
             Environmental Information Processing
              Signal transduction
               04010 MAPK signaling pathway
                3553 (IL1B)
               04064 NF-kappa B signaling pathway
                3553 (IL1B)
               04668 TNF signaling pathway
                3553 (IL1B)
              Signaling molecules and interaction
               04060 Cytokine-cytokine receptor interaction
                3553 (IL1B)
             Cellular Processes
              Cell growth and death
               04217 Necroptosis
                3553 (IL1B)
             Organismal Systems
              Immune system
               04640 Hematopoietic cell lineage
                3553 (IL1B)
               04620 Toll-like receptor signaling pathway
                3553 (IL1B)
               04621 NOD-like receptor signaling pathway
                3553 (IL1B)
               04623 Cytosolic DNA-sensing pathway
                3553 (IL1B)
               04659 Th17 cell differentiation
                3553 (IL1B)
               04657 IL-17 signaling pathway
                3553 (IL1B)
              Sensory system
               04750 Inflammatory mediator regulation of TRP channels
                3553 (IL1B)
              Development
               04380 Osteoclast differentiation
                3553 (IL1B)
             Human Diseases
              Immune diseases
               05323 Rheumatoid arthritis
                3553 (IL1B)
               05321 Inflammatiory bowel disease (IBD)
                3553 (IL1B)
               05332 Graft-versus-host disease
                3553 (IL1B)
              Neurodegenerative diseases
               05010 Alzheimer's disease
                3553 (IL1B)
               05020 Prion diseases
                3553 (IL1B)
              Cardiovascular diseases
               05418 Fluid shear stress and atherosclerosis
                3553 (IL1B)
              Endocrine and metabolic diseases
               04940 Type I diabetes mellitus
                3553 (IL1B)
               04932 Non-alcoholic fatty liver disease (NAFLD)
                3553 (IL1B)
               04933 AGE-RAGE signaling pathway in diabetic complications
                3553 (IL1B)
              Infectious diseases
               05132 Salmonella infection
                3553 (IL1B)
               05133 Pertussis
                3553 (IL1B)
               05134 Legionellosis
                3553 (IL1B)
               05152 Tuberculosis
                3553 (IL1B)
               05162 Measles
                3553 (IL1B)
               05164 Influenza A
                3553 (IL1B)
               05168 Herpes simplex infection
                3553 (IL1B)
               05146 Amoebiasis
                3553 (IL1B)
               05144 Malaria
                3553 (IL1B)
               05140 Leishmaniasis
                3553 (IL1B)
               05142 Chagas disease (American trypanosomiasis)
                3553 (IL1B)
               05143 African trypanosomiasis
                3553 (IL1B)
              Drug resistance
               01523 Antifolate resistance
                3553 (IL1B)
            Cytokines [BR:hsa04052]
             IL-1 family
              3553 (IL1B)
            Glycosaminoglycan binding proteins [BR:hsa00536]
             Heparan sulfate/Haparin
              Cytokines	(General comment) Chemotaxis, singal transduction, inflammation
               3553 (IL1B)
POSITION    2q14.1
MOTIF       Pfam: IL1 IL1_propep Inhibitor_I71
DBLINKS     NCBI-GeneID: 3553
            NCBI-ProteinID: NP_000567
            OMIM: 147720
            HGNC: 5992
            Ensembl: ENSG00000125538
            Vega: OTTHUMG00000131344
            Pharos: P01584(Tclin)
            UniProt: P01584
STRUCTURE   PDB: 4GAI 2NVH 1L2H 3POK 4G6M 1IOB 21BI 31BI 4I1B 2I1B 1I1B
                 4G6J 3LTQ 1TWE 1TOO 1T4Q 5I1B 5MVZ 4GAF 5BVP 1TP0 1TWM
                 9ILB 1S0L 1HIB 1ITB 41BI 4DEP 3O4O 2KH2 6I1B 7I1B
AASEQ       269
            MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKG
            FRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVR
            SLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKE
            KNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYIST
            SQAENMPVFLGGTKGGQDITDFTMQFVSS
NTSEQ       810
            atggcagaagtacctgagctcgccagtgaaatgatggcttattacagtggcaatgaggat
            gacttgttctttgaagctgatggccctaaacagatgaagtgctccttccaggacctggac
            ctctgccctctggatggcggcatccagctacgaatctccgaccaccactacagcaagggc
            ttcaggcaggccgcgtcagttgttgtggccatggacaagctgaggaagatgctggttccc
            tgcccacagaccttccaggagaatgacctgagcaccttctttcccttcatctttgaagaa
            gaacctatcttcttcgacacatgggataacgaggcttatgtgcacgatgcacctgtacga
            tcactgaactgcacgctccgggactcacagcaaaaaagcttggtgatgtctggtccatat
            gaactgaaagctctccacctccagggacaggatatggagcaacaagtggtgttctccatg
            tcctttgtacaaggagaagaaagtaatgacaaaatacctgtggccttgggcctcaaggaa
            aagaatctgtacctgtcctgcgtgttgaaagatgataagcccactctacagctggagagt
            gtagatcccaaaaattacccaaagaagaagatggaaaagcgatttgtcttcaacaagata
            gaaatcaataacaagctggaatttgagtctgcccagttccccaactggtacatcagcacc
            tctcaagcagaaaacatgcccgtcttcctgggagggaccaaaggcggccaggatataact
            gacttcaccatgcaatttgtgtcttcctaa
///
